Anito-cel (anitocabtagene autoleucel), a cell therapy in clinical development as a potential treatment for myeloma, may be less likely to cause side effects than…
Myeloma
If you visit the official website of World Cancer Day, which was Feb. 4, the first thing you’ll see are giant block letters scrolling…
If you are new to caregiving and expect to be handed a manual, just forget it. The real guidelines for…
A treatment regimen combining Darzalex Faspro (daratumumab and hyaluronidase-fihj) with three other medications is now approved in the U.S. for all people newly diagnosed…
The title of my column is “Hope Is My Superpower.” In my efforts to bring hope to multiple myeloma patients, I try to focus…
We carry many stories in our hearts. The story of how our own life should play out. The story of a peaceful retirement. The story…
A clinical trial in Australia that’s testing the genetic therapy KLN-1010 in people with hard-to-treat multiple myeloma has won regulatory approval to add new…
Today, Jan. 26, is the first day of tax season here in the U.S. Last week, our accountant emailed her annual reminder to collect the…
The other day, I discovered an old, folded road map in the glove compartment. It had faded colors and deep creases. After I spread it…
Treatment with Tecvayli (teclistamab) was better than standard therapies at delaying disease progression and prolonging survival among previously-treated myeloma patients in a Phase…
Recent Posts
- FDA approves cell therapy to reduce GVHD risk after transplant
- Regulators in 2 countries OK clinical testing of new blood cancer treatment
- The changing details of my mother’s hands tell her life story
- Glioblastoma trial adds new drug in search for better treatments
- Protein marker may help predict myeloma outcomes
